Skin Disease Clinical Trial
Official title:
Impact on UVB Narrow Band and UVA1 Therapy on Serum 25-hydroxyvitamin D Levels
We plan to investigate the serum elevation of 25(OH)D under UVB nb and UVA1 therapy, in order to determine the effect of these nowadays frequently used wavelengths for phototherapy on vitamin D plasma levels. We hope for a better understanding of steady-state and treatment-induced levels of vitamin D changes to better recognize the impact of phototherapy on vitamin D synthesis in the skin, the dimension of vitamin D production to be expected in the course of standard phototherapy and a potential gap in vitamin D production compared to physiological needs which then should be supplemented orally.
This is an open observational study in dermatological patients undergoing phototherapy.
In patients with a skin disease and the routinely given indication for a phototherapy with
UVB narrow-band (UVB nb, 311nm) or UVA1 (340-400 nm), the serum 25-hydroxyvitamin D,
calcium, parathormone, phosphate and albumin levels will be measured before, during and
after completion of the 12-week therapy (30 patients per group). Patients will be recruited
in the department of dermatology of the University Hospital Zürich in the outpatient clinic.
Following oral and written consent, serum 25-hydroxyvitamin D, calcium, parathormone,
phosphate and albumin levels will be measured before the therapy, one week after start as
well as after completion of the UVB nb/UVA1 therapy.
In parallel to the study the patients will be asked to fill in a questionnaire evaluating
the daily vitamin D consume (milk and milk products, fish, food enhanced in vitamin D,
multivitamin supplements), sun exposure per week during previous weeks, degree of tanning,
the use of sunscreen, the DLQI and Skindex-29.
A physical examination including clinical score where available will be performed at every
"checkpoint". During the first physical examination the Fitzpatrick-skin type of patient
will be recorded.
The following participant characteristics will be recorded: age, weight, body mass index
(BMI), phototype, skin disease, comorbidities, usual medication, and period of the year
where UVB nb/UVA1 therapy is performed (summer vs. winter), cumulative UVB nb/UVA1 doses.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02663921 -
Visible Light Study
|
N/A | |
Recruiting |
NCT01012453 -
A Randomised Clinical Trial in a Population of Health Care Workers With Hand Eczema
|
N/A | |
Not yet recruiting |
NCT05561595 -
Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma
|
N/A | |
Completed |
NCT02309905 -
Evaluation of Tele-expertise for Inmates With a Dermatological Lesion
|
N/A | |
Completed |
NCT02338076 -
A Study to Document the Effect of Petrolatum on Innate Immune Responses in the Skin
|
N/A | |
Completed |
NCT02465476 -
Rationalization of the Treatment Pathway of Patient Suffering From Rare Skin Disease With Telemedicine
|
N/A | |
Completed |
NCT00001648 -
Structure of the Herpes Simplex Virus Receptor
|
N/A | |
Completed |
NCT01187732 -
Washing Without Water: Cost-effectiveness of a Rapidly Spreading Nursing Intervention in Bedridden Patients'
|
N/A |